4.7 Article

Chemotherapy-induced release of ADAM17 bearing EV as a potential resistance mechanism in ovarian cancer

Related references

Note: Only part of the references are listed.
Article Oncology

Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer

Wenyu Wang et al.

Summary: This study aimed to identify EV miRNA biomarkers for ovarian cancer diagnosis and metastasis regulation, resulting in a panel of eight dysregulated miRNAs. The OCEM signature developed based on these eight miRNAs demonstrated high diagnostic accuracy across diverse clinical samples.

CANCER LETTERS (2022)

Review Oncology

Molecular mechanisms of platinum-based chemotherapy resistance in ovarian cancer

Ling Yang et al.

Summary: This article summarizes the latest understanding of mechanisms underlying platinum-based chemotherapy resistance in ovarian cancer and discusses current and emerging approaches for targeting these patients. Challenges associated with these approaches are also presented, with a focus on the importance of development and overcoming resistance.

ONCOLOGY REPORTS (2022)

Article Obstetrics & Gynecology

Updates and New Options in Advanced Epithelial Ovarian Cancer Treatment

Katherine C. Kurnit et al.

Summary: The medical and surgical treatment strategies for women with epithelial ovarian cancer are evolving, with advancements in complex surgical procedures, novel therapeutics, and genetic-driven treatment categories. Clinical trial enrollment is crucial for identifying novel strategies in the evolving landscape of treatments.

OBSTETRICS AND GYNECOLOGY (2021)

Review Biochemistry & Molecular Biology

Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer

Lucia Pascual-Anton et al.

Summary: Most ovarian cancer patients have peritoneal disseminated disease at diagnosis, with peritoneal mesothelial cells being a key barrier. Exosomes and mesothelial-to-mesenchymal transition play crucial roles in peritoneal colonization of ovarian cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

Ovarian Cancer, Version 2.2020

Deborah K. Armstrong et al.

Summary: Epithelial ovarian cancer is a leading cause of gynecologic cancer death in the United States. The NCCN Guidelines discuss various ovarian cancers, focusing on primary treatment aspects and including recommendations for both common and rare subtypes.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)

Review Engineering, Chemical

Extracellular Vesicle Transportation and Uptake by Recipient Cells: A Critical Process to Regulate Human Diseases

Zhi Hao Kwok et al.

Summary: Emerging evidence suggests that extracellular vesicles (EVs) play a significant role in modulating human diseases, but further research is needed to understand their transportation and uptake mechanisms. Understanding the specificity of EV transport is crucial for the development of EVs as valuable diagnostics and therapeutics.

PROCESSES (2021)

Review Immunology

Intra- and Extracellular Effector Vesicles From Human T And NK Cells: Same-Same, but Different?

Marcus Lettau et al.

Summary: CTL and NK cells use overlapping effector mechanisms to eliminate target cells, with effector proteins stored in lysosome-related effector vesicles. These vesicles not only contain cytolytic effectors, but also other immunomodulatory proteins, suggesting a direct relation between intra- and extracellular vesicles. This indicates a potential role for extracellular vesicles as additional effector vesicles or intercellular communicators in a systemic manner.

FRONTIERS IN IMMUNOLOGY (2021)

Article Oncology

ADAM17-A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer

Christoph Rogmans et al.

Summary: Ovarian cancer is characterized by high mortality rates due to late diagnosis and lack of early symptoms. ADAM17, a metalloprotease, shows promise as a potential diagnostic blood-based biomarker in ovarian cancer, as it is highly expressed in various solid tumors. This study found that ADAM17 was detected in ovarian cancer cell lines, primary cells, serum, and ascites of patients, with significantly higher levels in ovarian cancer patients compared to controls. Moreover, ADAM17 levels were elevated in early stages of the disease, suggesting its potential use in combination with other markers for early detection of ovarian cancer.

CANCERS (2021)

Review Pharmacology & Pharmacy

Extracellular Vesicles: A Novel Tool Facilitating Personalized Medicine and Pharmacogenomics in Oncology

Katja Goricar et al.

Summary: EVs have emerged as a potential source of biomarkers in liquid biopsy, offering valuable insights for personalized cancer treatment in oncology.

FRONTIERS IN PHARMACOLOGY (2021)

Article Oncology

ADAM17 Inhibition Increases the Impact of Cisplatin Treatment in Ovarian Cancer Spheroids

Nina Hedemann et al.

Summary: Treatment of ovarian cancer (OvCa) remains challenging due to acquired resistance mechanisms during chemotherapy. Combination therapy of the ADAM17 inhibitor GW280264X with cisplatin shows enhanced cytotoxicity, offering a promising strategy to overcome chemotherapy resistance in OvCa.

CANCERS (2021)

Article Biochemistry & Molecular Biology

Cellular Integrin α5β1 and Exosomal ADAM17 Mediate the Binding and Uptake of Exosomes Produced by Colorectal Carcinoma Cells

Beatriz Cardenes et al.

Summary: Research has shown that the interaction between integrin alpha 5 beta 1 on CRC cells and their ligand ADAM17 mediates the binding and uptake of CRC-derived exosomes, while the expression of CD9 on exosomes negatively regulates this process.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Multidisciplinary Sciences

The biology, function, and biomedical applications of exosomes

Raghu Kalluri et al.

SCIENCE (2020)

Review Pharmacology & Pharmacy

An emerging focus on lipids in extracellular vesicles

Tore Skotland et al.

ADVANCED DRUG DELIVERY REVIEWS (2020)

Review Pharmacology & Pharmacy

Leukobiopsy - A Possible New Liquid Biopsy Platform for Detecting Oncogenic Mutations

Shilpa Chennakrishnaiah et al.

FRONTIERS IN PHARMACOLOGY (2020)

Review Biochemistry & Molecular Biology

Microvesicles in Cancer: Small Size, Large Potential

Kerstin Menck et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Oncology

Exosomes as a Multicomponent Biomarker Platform in Cancer

Valerie S. LeBleu et al.

TRENDS IN CANCER (2020)

Review Oncology

Ovarian Cancer: An Integrated Review

Christine Stewart et al.

SEMINARS IN ONCOLOGY NURSING (2019)

Review Pathology

The metalloprotease ADAM17 in inflammation and cancer

Stefan Duesterhoeft et al.

PATHOLOGY RESEARCH AND PRACTICE (2019)

Article Biochemistry & Molecular Biology

The biology of extracellular vesicles: The known unknowns

Leonid Margolis et al.

PLOS BIOLOGY (2019)

Review Oncology

Impact of Chemotherapy on Extracellular Vesicles: Understanding the Chemo-EVs

Nur' Syahada Ab Razakl et al.

FRONTIERS IN ONCOLOGY (2019)

Article Biochemistry & Molecular Biology

Vesiclepedia 2019:a compendium of RNA, proteins, lipids and metabolites in extracellular vesicles

Mohashin Pathan et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Biology

Cisplatin induces the release of extracellular vesicles from ovarian cancer cells that can induce invasiveness and drug resistance in bystander cells

Priya Samuel et al.

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2018)

Article Oncology

Ovarian cancer-derived extracellular vesicles affect normal human fibroblast behavior

Ilaria Giusti et al.

CANCER BIOLOGY & THERAPY (2018)

Review Cell Biology

Shedding light on the cell biology of extracellular vesicles

Guillaume van Niel et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)

Article Medicine, General & Internal

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

K. Moore et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Biochemistry & Molecular Biology

Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17

Petra C. Buchanan et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2017)

Article Oncology

Exosomes as mediators of platinum resistance in ovarian cancer

Jennifer Crow et al.

ONCOTARGET (2017)

Article Biochemistry & Molecular Biology

The shedding protease ADAM17: Physiology and pathophysiology

Friederike Zunke et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)

Article Biochemistry & Molecular Biology

Metalloproteinases in extracellular vesicles

Masayuki Shimoda et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)

Review Biochemistry & Molecular Biology

Molecular insights into the multilayered regulation of ADAM17: The role of the extracellular region

Joachim Groetzinger et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)

Article Biochemistry & Molecular Biology

Stimulated release and functional activity of surface expressed metalloproteinase ADAM17 in exosomes

Esther Groth et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)

Editorial Material Cell Biology

How membrane asymmetry regulates ADAM17 sheddase function

Anselm Sommer et al.

CELL CYCLE (2016)

Article Multidisciplinary Sciences

Phosphatidylserine exposure is required for ADAM17 sheddase function

Anselm Sommer et al.

NATURE COMMUNICATIONS (2016)

Correction Multidisciplinary Sciences

Control of ADAM17 activity by regulation of its cellular localisation (vol 6, 35067, 2016)

Inken Lorenzen et al.

SCIENTIFIC REPORTS (2016)

Article Multidisciplinary Sciences

Massive release of extracellular vesicles from cancer cells after photodynamic treatment or chemotherapy

Kelly Aubertin et al.

SCIENTIFIC REPORTS (2016)

Review Cell Biology

Ectosomes and exosomes: shedding the confusion between extracellular vesicles

Emanuele Cocucci et al.

TRENDS IN CELL BIOLOGY (2015)

Review Cell Biology

Biogenesis and secretion of exosomes

Joanna Kowal et al.

CURRENT OPINION IN CELL BIOLOGY (2014)

Article Biotechnology & Applied Microbiology

Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor

Hyungsoon Im et al.

NATURE BIOTECHNOLOGY (2014)

Review Oncology

Novel insights into exosome-induced, tumor-associated inflammation and immunomodulation

Peter Altevogt et al.

SEMINARS IN CANCER BIOLOGY (2014)

Review Cell Biology

Routes and mechanisms of extracellular vesicle uptake

Laura Ann Mulcahy et al.

JOURNAL OF EXTRACELLULAR VESICLES (2014)

Article Oncology

The disintegrin domain of ADAM17 antagonises fibroblast-carcinoma cell interactions

Ahmad Trad et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2013)

Review Cell Biology

Extracellular vesicles: Exosomes, microvesicles, and friends

Graca Raposo et al.

JOURNAL OF CELL BIOLOGY (2013)

Article Biochemistry & Molecular Biology

MicroRNAs are exported from malignant cells in customized particles

Jaime Palma et al.

NUCLEIC ACIDS RESEARCH (2012)

Review Biochemistry & Molecular Biology

Molecular mechanisms of cisplatin resistance

L. Galluzzi et al.

ONCOGENE (2012)

Article Multidisciplinary Sciences

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

Martin Jinek et al.

SCIENCE (2012)

Article Biochemistry & Molecular Biology

Amphiregulin Exosomes Increase Cancer Cell Invasion

James N. Higginbotham et al.

CURRENT BIOLOGY (2011)

Article Multidisciplinary Sciences

Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17

Thorsten Maretzky et al.

NATURE COMMUNICATIONS (2011)

Review Biochemistry & Molecular Biology

ADAM-17: the enzyme that does it all

Monika Gooz

CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)

Review Biochemistry & Molecular Biology

The ADAM metalloproteinases

Dylan R. Edwards et al.

MOLECULAR ASPECTS OF MEDICINE (2008)

Article Biochemistry & Molecular Biology

Ectodomain shedding of the EGF-receptor ligand epigen is mediated by ADAM17

Umut Sahin et al.

FEBS LETTERS (2007)

Article Biochemistry & Molecular Biology

A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44

A Stoeck et al.

BIOCHEMICAL JOURNAL (2006)

Review Cell Biology

Adams: Key components in EGFR signalling and development

CP Blobel

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)

Review Oncology

Molecular mechanisms of drug resistance

DB Longley et al.

JOURNAL OF PATHOLOGY (2005)

Article Biochemistry & Molecular Biology

Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling

A Mandic et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

Article Oncology

Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation

R. Z. Yusuf et al.

CURRENT CANCER DRUG TARGETS (2003)

Article Biochemistry & Molecular Biology

Requirement for ERK activation in cisplatin-induced apoptosis

XT Wang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2000)